Bone metastases diagnosis possibilities in studies with the use of 18NaF and 18F-FDG

Nuclear Medicine Review

Volumn 14, Issue 2, 2011, Pages 105-108

  Tarnawska Pierścińska, Małgorzata ^a   Hołody, Łukasz ^a   Braziewicz, Janusz ^b   Królicki, Leszek ^c  

^a Holycross Cancer Centre   (Poland)

^b JAN KOCHANOWSKI UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Bone metastases; Breast cancer; Fluorodeoxyglucose 18F FDG; Lung cancer; Methylene diphosphonate 99mTc MDP; Prostate cancer; Sodium fluoride 18F NaF

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE TECHNETIUM TC 99M; CHOLINE; CHOLINE FLUORINE F 18; DOTATATE GADOLINIUM GA 68; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IODINE 131; MEDRONATE TECHNETIUM TC 99M; OCTREOTIDE; SODIUM FLUORIDE F 18; TECHNETIUM 99M; TETRAXETAN; UNCLASSIFIED DRUG;

BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

BONE NEOPLASMS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SODIUM FLUORIDE; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856638152     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: 10.5603/NMR.2011.00024     Document Type: Review

References (12)

1. Even Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities J Nucl Med 2005; 46: 1356-1367.
2. Królicki L. Medycyna nuklearna. Warszawa 1996.
3. Grant FD. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med 2008; 49: 68-78.
4. Blau M, Nagler W, Bender M. Fluorine-18: a new isotope for bone scanning. J Nucl Med 1962; 3: 332-334.
5. Cook GJR. The role of position emission tomography in the management of bone metastases. Cancer 2000; 88 (suppl): 2927-2933. (Pubitemid 30413175)
6. 18F-NaF deposition. J Nucl Med 2010; 51: 1826-1829.
7. 18F-fluoride PET/CT J Nucl Med 2006; 47: 287-297.
8. Sodium Fluoride F18 injection investigator's brochure -Cancer Imaging Program Division of Cancer Treatment and Diagnosis National Institutes of Health 6130 Executive Blvd. Edition 1, August 2008
9. 99mTc-MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer. J Korean Med Sci 2009; 24: 275-280
10. Schirrmeister H, Guhlmann A, Eisner K et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med 1999, 40: 1623-1629. (Pubitemid 29471151)
11. Bury T, Barreto A, Daenen F et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 25: 1244-1247. (Pubitemid 28446049)
12. Metser U, Lerman H, Blank A et al. Malignant involvement of the spine: assessment by 18F-fluorodeoxyglucose PET/CT. J Nucl Med 2004; 45: 279-284. (Pubitemid 47618649)